CD274 and cancer: Likewise, it has been shown in other systems that the aberrant expression of immune evasion receptors (e.g., PD-L1) is metabolically controlled45, and in cancer, correlations between metabolic alterations, EMT, and PD-L1 upregulation have been demonstrated46.